Adam S. Taich has served as Chief Financial Officer of 10x Genomics since August 2024, also serving as Treasurer, principal financial officer and principal accounting officer.
He previously was Chief Strategy Officer of Standard BioTools from January 2024 to July 2024 and interim CEO of SomaLogic from March 2023 until its acquisition by Standard BioTools in January 2024, having also served as SomaLogic's Chief Business Officer and EVP of Life Sciences. Before that he spent 19 years at Thermo Fisher Scientific in roles including Vice President & General Manager-Molecular Biology and Vice President-Strategy and Business Development.
He holds a B.A. in Political Science and Russian from Miami University in Oxford, Ohio.